DA
GH icon

Duality Advisers’s Guardant Health GH Stock Holding History

Duality Advisers’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-55,952
Closed -$1.15M – 213
2024
Q1 		$1.15M Buy
+55,952
New +$1.2M 0.11% 293
2021
Q3 		– Sell
-6,942
Closed -$862K – 602
2021
Q2 		$862K Buy
+6,942
New +$934K 0.08% 360

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Duality Advisers's GH Position: Q2 2024 in Review

Duality Advisers sold out of Guardant Health (GH) in Q2 2024, closing a stake of 55,952 shares — an estimated $1.15M sold.

Duality Advisers first reported a position in GH in Q2 2021 and held it in 2 quarters. The position peaked at $1.15M in Q1 2024. 281 funds tracked by Wall St. Rank hold GH as of Q2 2024.

  • Duality Advisers reported no remaining Guardant Health position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 55,952 Guardant Health shares in Q2 2024, an estimated $1.15M.
  • Duality Advisers first reported a position in Guardant Health in Q2 2021 and held it in 2 quarters.
  • Duality Advisers's Guardant Health position peaked at $1.15M in Q1 2024.
  • 281 funds tracked by Wall St. Rank held Guardant Health as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.